Showing results (121-130 of 171) with videos related to

Sort By:
Pageof 18
Environmental Pollution (Barking, Essex : 1987)|September 29, 2023
Multigenerational tests on Daphnia spp.: a vision and new perspectivesE G Padilla Suarez, S Pugliese, E Galdiero, et al.
International Journal of Oncology|May 18, 2011
Subcutaneous ril-2 in advanced melanoma and kidney carcinomaM Delena, M Guida, A Casamassima, et al.
Journal of Hazardous Materials|July 25, 2016
Removal of benzoylecgonine from water matrices through UV254/H2O2 process: Reaction kinetic modeling, ecotoxicity and genotoxicity assessmentD Spasiano, D Russo, M Vaccaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). A phase II study of the GOIM (Gruppo Oncologico dell'Italia Meridionale)V Lorusso, M Spada, M Giampaglia, et al.
Journal of Clinical Medicine|January 27, 2021
Preoperative Immunonutrition vs. Standard Dietary Advice in Normo-Nourished Patients Undergoing Fast-Track Laparoscopic Colorectal SurgeryManfredi Tesauro, Andrea M Guida, Leandro Siragusa, et al.
Tumori|October 31, 1994
Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different nosological entities?M Guida, A Casamassima, I Abbate, et al.
The Journal of Liquid Biopsy|January 26, 2026
Tissue expression of miR-504-5p and miR-429 as diagnostic biomarkers for endometrial cancer and endometrial intraepithelial neoplasia: a pilot studyA Manzi, C De Luca, F Conticelli, et al.
International Journal of Oncology|May 6, 2011
Accelerated neoadjuvant chemotherapy of non-small cell lung cancer (NSCLC)V Lorusso, F Carpagnano, G Dirienzo, et al.
British Journal of Cancer|July 22, 2004
Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patientsP Comella, G Frasci, P Carnicelli, et al.
Tumori|May 6, 1999
Mitoxantrone, L-leucovorin and 5-fluorouracil: an effective and well tolerated first-line treatment for advanced breast cancerV Lorusso, S Mancarella, A Catino, et al.
Pageof 18